These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine-Fluoxetine Study Group. Wheatley DP, van Moffaert M, Timmerman L, Kremer CM. J Clin Psychiatry; 1998 Jun; 59(6):306-12. PubMed ID: 9671343 [Abstract] [Full Text] [Related]
13. Somatic symptoms as predictors of time to onset of response to fluoxetine in major depressive disorder. Papakostas GI, Petersen TJ, Iosifescu DV, Summergrad P, Sklarsky KG, Alpert JE, Nierenberg AA, Fava M. J Clin Psychiatry; 2004 Apr; 65(4):543-6. PubMed ID: 15119918 [Abstract] [Full Text] [Related]
14. The pharmacotherapy of depressive illness in adolescents: an open-label comparison of fluoxetine with imipramine-treated historical controls. Strober M, DeAntonio M, Schmidt-Lackner S, Pataki C, Freeman R, Rigali J, Rao U. J Clin Psychiatry; 1999 Mar; 60(3):164-9. PubMed ID: 10192591 [Abstract] [Full Text] [Related]
20. Do depressed subjects who have failed both fluoxetine and a tricyclic antidepressant respond to the combination? Levitt AJ, Joffe RT, Kamil R, McIntyre R. J Clin Psychiatry; 1999 Sep; 60(9):613-6. PubMed ID: 10520980 [Abstract] [Full Text] [Related] Page: [Next] [New Search]